Cargando…
Model‐based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus
AIMS: To quantitatively describe the relationship between dapagliflozin systemic exposure and HbA1c response among patients with type 1 diabetes mellitus (T1DM) and assess the potential impact of covariate effects. MATERIALS AND METHODS: Individual longitudinal HbA1c data from two phase 3 studies in...
Autores principales: | Parkinson, Joanna, Tang, Weifeng, Åstrand, Magnus, Melin, Johanna, Ekholm, Ella, Hamrén, Bengt, Boulton, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594233/ https://www.ncbi.nlm.nih.gov/pubmed/30756462 http://dx.doi.org/10.1111/dom.13664 |
Ejemplares similares
-
Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Diabetes Mellitus
por: Melin, Johanna, et al.
Publicado: (2022) -
Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients
por: Wang, Dong-Dong, et al.
Publicado: (2023) -
Urinary glucose excretion after dapagliflozin treatment: An exposure‐response modelling comparison between Japanese and non‐Japanese patients diagnosed with type 1 diabetes mellitus
por: Sokolov, Victor, et al.
Publicado: (2018) -
Role of HbA1c in post-partum screening of women with gestational diabetes mellitus
por: Claesson, Rickard, et al.
Publicado: (2014) -
HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome
por: Odsæter, Ingrid Hov, et al.
Publicado: (2015)